Finally, ψ-bufarenogin is a high-/intermediate polarity compound that showed satisfactory therapeutic effect against liver cancer xenografts by suppressing the MAPK and PI3K/Akt pathways [54]. This evidence concerns the gene PIK3CA and liver cancer.